Highlights Newsletter 2
This newsletter presents you the following key sessions:
4. Trastuzumab deruxtecan effectively treats HER2-expressing cancers regardless of tumour location
This newsletter presents you the following key sessions:
4. Trastuzumab deruxtecan effectively treats HER2-expressing cancers regardless of tumour location
Medical writer
Medical writer
Medical writer